1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Delayed Effects, Prenatal Exposure in 5 studies
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Idiopathic Parkinson's disease (PD) is a neurodegenerative disorder of mature and older individuals." | 1.36 | Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. ( Charlton, CG; King, J; Mackey, V; Muthian, G, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muthian, G | 1 |
| Mackey, V | 1 |
| King, J | 1 |
| Charlton, CG | 1 |
| Lloyd, SA | 1 |
| Faherty, CJ | 1 |
| Smeyne, RJ | 1 |
| Pérez-Otaño, I | 1 |
| Oset, C | 1 |
| Trinidad Herrero, M | 1 |
| Luquin, MR | 1 |
| Kupsch, A | 1 |
| Oertel, W | 1 |
| Obeso, JA | 1 |
| Del Río, J | 1 |
| Ochi, N | 1 |
| Naoi, M | 1 |
| Mogi, M | 1 |
| Ohya, Y | 1 |
| Mizutani, N | 1 |
| Watanabe, K | 1 |
| Harada, M | 1 |
| Nagatsu, T | 1 |
| Weissman, EM | 1 |
| Norman, AB | 1 |
| Calderon, SF | 1 |
| Zubrycki, EM | 1 |
| el-Etri, MM | 1 |
| Shipley, MT | 1 |
| Sanberg, PR | 1 |
5 other studies available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Delayed Effects, Prenatal Exposure
| Article | Year |
|---|---|
Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Birth | 2010 |
Adult and in utero exposure to cocaine alters sensitivity to the Parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Count; Cocaine; DNA Primers; Dopamine Ag | 2006 |
Neurotoxic effect of prenatal exposure to MPTP on the dopaminergic systems of the marmoset brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Adolescent; Animals; C | 1992 |
Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in prenatal stage on the dopamine system in the postnatal mouse brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Abortion, Veterinary; Animals; Brain; Dopamine; Dose-R | 1991 |
The effect of prenatal treatment with MPTP or MPP+ on the development of dopamine-mediated behaviors in rats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Amphetamines; Animals; Ap | 1989 |